HOLON, Israel (AP) _ Compugen Ltd. (CGEN) on Thursday reported a loss of $8.6 million in its fourth quarter.

The Holon, Israel-based company said it had a loss of 10 cents per share.

The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.

The drug developer posted revenue of $2 million in the period.

For the year, the company reported that its loss widened to $29.7 million, or 37 cents per share. Revenue was reported as $2 million.

Compugen shares have fallen 14% since the beginning of the year. The stock has climbed 14% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News